Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOAAL: Losartan vs Amlodipine in Hypertension with Metabolic Risk
NCT00237588Phase 4Completed
- Sponsor
- Ullevål University Hospital
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of losartan in hypertension (HTN) (2 arms), sponsored by Ullevål University Hospital. Primary endpoint: Insulin sensitivity assessed with hyperinsulinaemic isoglycaemic glucose clamp (GDR). Started Dec 2004; status: completed.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00237588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237588.